SCHEMBL2489842

SCHEMBL2489842

CCOC(=O)c1sc(N)nc1-c1cccc(Cl)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.73
▸ HSD17B10 Q99714 2/20 0.73
▸ TRPM8 Q7Z2W7 1/20 0.63
▸ RORB Q92753 1/20 0.60
▸ DHODH Q02127 5/20 0.54
▸ PDE4A P27815 1/20 0.54
▸ PDE4B Q07343 1/20 0.54
▸ PDE4C Q08493 1/20 0.54
▸ PDE4D Q08499 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ CDC7 O00311 2/20 0.52
▸ DBF4 Q9UBU7 2/20 0.52
▸ CFTR P13569 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ HPGD P15428 3/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492109 0.88 TRPM8 (0.65) ALDH1A1HSD17B10TRPM8DHODHPDE4A
SCHEMBL1968418 0.88 TRPM8 (0.65) ALDH1A1HSD17B10TRPM8DHODHPDE4A
SCHEMBL11164259 0.88 ALDH1A1 (0.77) ALDH1A1HSD17B10DHODHKDM4EMAPT
SCHEMBL1920374 0.87 TRPM8 (0.64) ALDH1A1HSD17B10TRPM8DHODHPDE4A
SCHEMBL24508984 0.86 ALDH1A1 (0.73) ALDH1A1HSD17B10TRPM8DHODHKDM4E
SCHEMBL18342059 0.86 ALDH1A1 (0.73) ALDH1A1HSD17B10TRPM8RORBDHODH
SCHEMBL11161509 0.85 ALDH1A1 (0.76) ALDH1A1HSD17B10TRPM8DHODHKDM4E
SCHEMBL330552 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10TRPM8DHODHKDM4E
SCHEMBL18342124 0.84 ALDH1A1 (0.70) ALDH1A1HSD17B10TRPM8DHODHKDM4E
SCHEMBL11165291 0.83 ALDH1A1 (0.69) ALDH1A1HSD17B10RORBDHODHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379543-A2 THIAZOLYL-BENZIMIDAZOLES F. Hoffmann-La Roche AG (CH) 2011-10-26 — — EP disclosed
US-8044213-B2 Thiazolyl-benzimidazoles HOFFMANN-LA ROCHE INC. (US) 2011-10-25 — — US disclosed
WO-2010121675-A2 THIAZOLYL-BENZIMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 — — WO disclosed
US-20100160308-A1 Thiazolyl-Benzimidazoles CAI JIANPING 2010-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160308-A1 Thiazolyl-Benzimidazoles CYP3A7, CYP2C19, CYP3A5 ALDH1A1 100/4885HSD17B10 683/4885TRPM8 2617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback